title: A case with euprolactinemic galactorrhea induced by escitalopram.
abstract: Endocrine and reproductive side effects of serotonergic antidepressants are uncommon and galactorrhea is only rarely mentioned among SSRI-related side effects. Perhaps through suppression of dopamine neurotransmission releasing prolactin from tonic inhibitor control of dopamine, serotonin-enhancing antidepressants may result in a rise in prolactin levels. However, we here describe a case of euprolactinemic galactorrhea induced by the SSRI escitalopram and discuss potential mechanisms of action.
authors.affiliation: Isparta Military Hospital, Psychiatry Service, Turkey. mgulsun@gmail.com
authors.forename: Murat
authors.initials: M
authors.lastname: Gulsun
authors.forename: Ayhan
authors.initials: A
authors.lastname: Algul
authors.forename: Umit Basar
authors.initials: UB
authors.lastname: Semiz
authors.forename: Mehmet Alpay
authors.initials: MA
authors.lastname: Ates
authors.forename: Ali
authors.initials: A
authors.lastname: Doruk
authors.forename: Servet
authors.initials: S
authors.lastname: Ebrinc
authors.forename: Cengiz
authors.initials: C
authors.lastname: Basoglu
authors.forename: Mesut
authors.initials: M
authors.lastname: Cetin
mesh_terms: D000328:Adult; D015283:Citalopram / Q000009:adverse effects* / Q000627:therapeutic use; D015897:Comorbidity; D004334:Drug Administration Schedule; D005260:Female; D005687:Galactorrhea / Q000097:blood / Q000139:chemically induced* / Q000453:epidemiology; D006801:Humans; D006966:Hyperprolactinemia / Q000453:epidemiology; D016584:Panic Disorder / Q000097:blood / Q000188:drug therapy*; D011388:Prolactin / Q000097:blood*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D015283:Citalopram; D011388:Prolactin; D017367:Selective Serotonin Reuptake Inhibitors